Mouse Monoclonal CUG-BP1 antibody. Suitable for ICC, WB, IHC-P and reacts with Human samples. Cited in 24 publications.
View Alternative Names
BRUNOL2, CUGBP, CUGBP1, NAB50, CELF1, CUGBP Elav-like family member 1, CELF-1, 50 kDa nuclear polyadenylated RNA-binding protein, Bruno-like protein 2, CUG triplet repeat RNA-binding protein 1, CUG-BP- and ETR-3-like factor 1, Deadenylation factor CUG-BP, Embryo deadenylation element-binding protein homolog, RNA-binding protein BRUNOL-2, CUG-BP1, EDEN-BP homolog
- ICC
Lab
Immunocytochemistry - Anti-CUG-BP1 antibody [3B1] (AB9549)
ab9549 staining CUG-BP1 in HeLa cells. The cells were fixed with 4% paraformaldehyde (10 min), permeabilized with 0.1% PBS-Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1%PBS-Tween for 1h. The cells were then incubated overnight at 4°C with ab9549 at 1µg/ml and ab6046, Rabbit polyclonal to beta Tubulin - Loading Control. Cells were then incubated with ab150117, Goat polyclonal Secondary Antibody to Mouse IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 dilution (shown in green) and ab150080, Goat polyclonal Secondary Antibody to Rabbit IgG - H&L (Alexa Fluor® 594) at 1/1000 dilution (shown in pseudocolour red). Nuclear DNA was labelled with DAPI (shown in blue).
Also suitable in cells fixed with 100% methanol (5 min).
Image was acquired with a high-content analyser (Operetta CLS, Perkin Elmer) and a maximum intensity projection of confocal sections is shown.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CUG-BP1 antibody [3B1] (AB9549)
IHC image of CUG-BP1 staining in human normal kidney formalin fixed paraffin embedded tissue section*, performed on a Leica Bond™ system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab9549, 5μg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
*Tissue obtained from the Human Research Tissue Bank, supported by the NIHR Cambridge Biomedical Research Centre
- WB
Lab
Western blot - Anti-CUG-BP1 antibody [3B1] (AB9549)
Lanes 1-4 : Merged signal (red and green). Green - ab9549 observed at 52 kDa. Red - loading control ab181602 observed at 36 kDa.
ab9549 Anti-CUG-BP1 antibody [3B1] was shown to specifically react with CUG-BP1 in wild-type HEK293T cells. Loss of signal was observed when knockout cell line ab266086 (knockout cell lysate ab257390) was used. Wild-type and CUG-BP1 knockout samples were subjected to SDS-PAGE. ab9549 and Anti-GAPDH antibody[EPR16891] - Loading Control (ab181602) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 680RD) preadsorbed (ab216777) and Goat anti-Mouse IgG H&L (IRDye® 800CW) preadsorbed (ab216772) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-CUG-BP1 antibody [3B1] (ab9549) at 1/1000 dilution
Lane 1:
Wild-type HEK293T cell lysate at 20 µg
Lane 2:
CELF1 knockout HEK293T cell lysate at 20 µg
Lane 3:
HeLa cell lysate at 20 µg
Lane 4:
Human brain tissue lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (IRDye® 680RD) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-680rd-preadsorbed-ab216777'>ab216777</a>) at 1/10000 dilution
Predicted band size: 52 kDa
Observed band size: 52 kDa
false
- WB
Lab
Western blot - Anti-CUG-BP1 antibody [3B1] (AB9549)
All lanes:
Western blot - Anti-CUG-BP1 antibody [3B1] (ab9549) at 1 µg/mL
Lane 1:
HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate at 10 µg
Lane 2:
SHSY-5Y (Human neuroblastoma cell line) Whole Cell Lysate at 10 µg
Lane 3:
Human kidney tissue lysate - total protein (<a href='/en-us/products/unavailable/human-kidney-tissue-lysate-total-protein-ab30203'>ab30203</a>) at 10 µg
Secondary
All lanes:
Goat polyclonal to Mouse IgG - H&L - Pre-Adsorbed (HRP) at 1/5000 dilution
Predicted band size: 52 kDa
Observed band size: 54 kDa
true
Exposure time: 20min
Reactivity data
Product details
This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The regulation by CUG-BP1 affects both mRNA stability and translation. The protein plays an important role in managing the expression of genes involved in muscle differentiation and development. CUG-BP1 often interacts with other cellular machinery forming functional complexes to facilitate its role in RNA metabolism. Its capacity to bind CUG motifs on target RNA highlights its significance in cellular processes.
Pathways
CUG-BP1 participates in pathways influencing muscle formation and maintenance. It plays part in the regulation of alternative splicing processes critical for efficient functioning of the p38 MAPK pathway. This pathway connects CUG-BP1 to other RNA-binding proteins and kinases. By doing so it affects different transcriptional and post-transcriptional processes emphasizing its critical function in cellular maintenance.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (24)
Recent publications for all applications. Explore the full list and refine your search
Life science alliance 8: PubMed39622621
2024
Applications
Unspecified application
Species
Unspecified reactive species
Annals of neurology 93:155-163 PubMed36251395
2022
Applications
Unspecified application
Species
Unspecified reactive species
JCI insight 7: PubMed36040809
2022
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 12:5208 PubMed34471108
2021
Applications
Unspecified application
Species
Unspecified reactive species
MethodsX 8:101376 PubMed34430272
2021
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 21: PubMed33297405
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cancer immunology research : PubMed32999004
2020
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 11:196 PubMed32231562
2020
Applications
Unspecified application
Species
Unspecified reactive species
Investigative ophthalmology & visual science 60:3980-3991 PubMed31560764
2019
Applications
Unspecified application
Species
Unspecified reactive species
Drug metabolism and disposition: the biological fa 47:314-319 PubMed30606728
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com